CompanyGraph
Emergent BioSolutions Inc.
EBS · NYSE Arca · United States
emergentbiosolutions.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $770.2M, above the global median of $548.88M
- FinancialsAltman Z-Score 1.47: grey zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
348.15MUSDvs all stocks (USD)
Revenue (TTM)
770.20MUSDvs all stocks (USD)
Profit Margin
-22.96%Beta
2.34xvs all stocks
52-Week Change
-24.05%vs all stocks
Market Capitalization
348.15MUSDvs all stocks (USD)
Enterprise Value
796.65MUSDvs all stocks (USD)
Forward P/E
6.49xPrice to Sales (TTM)
0.4520xPrice to Book (MRQ)
1.02xEnterprise to Revenue
1.03xEnterprise to EBITDA
3.43xGross Margin
57.19%Profit Margin
-22.96%Operating Margin
28.34%Return on Assets (TTM)
6.93%Return on Equity (TTM)
-40.29%Revenue (TTM)
770.20MUSDvs all stocks (USD)
Revenue per Share (TTM)
14.76USDUpdated Sep 27, 2026Quarterly Revenue Growth
66.30%Gross Profit (TTM)
388.50MUSDvs all stocks (USD)
EBITDA (TTM)
262.30MUSDvs all stocks (USD)
Net Income (TTM)
-176.80MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
74.06%Operating Cash Flow (TTM)
97.70MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
37.50MUSDvs all stocks (USD)
Payout Ratio
0.00%Revenue
705.20MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
326.20MUSDFY2025 · Dec 31, 2025Gross Profit
379.00MUSDFY2025 · Dec 31, 2025Operating Income
112.30MUSDvs all stocks (USD)
Pre-tax Income
82.80MUSDFY2025 · Dec 31, 2025Income Tax Expense
30.20MUSDFY2025 · Dec 31, 2025Net Income
52.60MUSDFY2025 · Dec 31, 2025EBIT
142.10MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
262.30MUSDFY2025 · Dec 31, 2025Research & Development
53.20MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
186.10MUSDFY2025 · Dec 31, 2025Other Operating Expenses
-37.70MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
59.30MUSDFY2025 · Dec 31, 2025EPS (Basic)
0.9800USDFY2025 · Dec 31, 2025EPS (Diluted)
0.9300USDFY2025 · Dec 31, 2025Basic Shares Outstanding
53.50MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
53.50MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
52.60MUSDFY2025 · Dec 31, 2025Operating Cash Flow
164.20MUSDFY2025 · Dec 31, 2025Free Cash Flow
139.80MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
209.10MUSDFY2025 · Dec 31, 2025Income Tax Paid
40.00MUSDFY2025 · Dec 31, 2025Interest Paid
49.70MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
52.60MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
95.80MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-4.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
16.20MUSDFY2025 · Dec 31, 2025Other Non-cash Items
10.20MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
25.50MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-8.40MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-23.70MUSDFY2025 · Dec 31, 2025Capital Expenditures
24.40MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Other Investing Activity
45.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
69.40MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-108.70MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-24.90MUSDFY2025 · Dec 31, 2025Other Financing Charges
-5.20MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-138.80MUSDFY2025 · Dec 31, 2025Shares Outstanding
51.30MSharesUpdated Sep 27, 2026Float Shares
49.07MSharesUpdated Sep 27, 2026Shares Short
9.79MSharesUpdated Sep 27, 2026Short Ratio
8.42daysvs all stocks
Short % of Shares Outstanding
19.39%vs all stocks
% Held by Insiders
4.26%vs all stocks
% Held by Institutions
90.73%vs all stocks
Total Cash (MRQ)
139.70MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.73USDUpdated Sep 27, 2026Total Debt (MRQ)
588.20MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.72xCurrent Ratio (MRQ)
5.42xBook Value per Share (MRQ)
6.66USDUpdated Sep 27, 2026Total Assets
1.32BUSDvs all stocks (USD)
Total Current Assets
662.50MUSDFY2025 · Dec 31, 2025Total Liabilities
796.00MUSDFY2025 · Dec 31, 2025Total Non-current Assets
656.10MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
663.80MUSDFY2025 · Dec 31, 2025Total Current Liabilities
132.20MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
205.40MUSDFY2025 · Dec 31, 2025Accounts Receivable
66.80MUSDFY2025 · Dec 31, 2025Inventory
343.40MUSDFY2025 · Dec 31, 2025Accounts Payable
55.60MUSDFY2025 · Dec 31, 2025Other Current Liabilities
15.80MUSDFY2025 · Dec 31, 2025Long-term Debt
572.10MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
53.90MUSDFY2025 · Dec 31, 2025Common Stock (Book)
100.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-159.80MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
522.60MUSDvs all stocks (USD)
Treasury Stock
252.60MUSDFY2025 · Dec 31, 202552-Week Low
4.36USDUpdated Sep 27, 202652-Week High
14.06USDUpdated Sep 27, 202652-Week Change
-24.05%vs all stocks
Beta
2.34xvs all stocks
50-Day MA
6.25USDUpdated Sep 27, 2026200-Day MA
8.75USDUpdated Sep 27, 2026Avg 10-Day Volume
1.18MSharesUpdated Sep 27, 2026Avg 30-Day Volume
1.19MSharesUpdated Sep 27, 2026Diluted EPS (TTM)
-3.41USDUpdated Sep 27, 2026Other Income / Expense
29.80MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.57Profit Margin: -0.23
Financial Health
Altman Z-Score 1.47: grey zoneSignificant
Altman Z-Score: 1.47
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $770.2M, above the global median of $548.88MNotable
Revenue (USD): 770,200,000Global Median: 548,883,780.48
Levered free cash flow is $37.5M, above the global median of $18.73MNotable
Levered free cash flow (USD): 37,500,000Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Hainan Huluwa Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Surrozen, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Jiangsu GDK Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Enanta Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shoulder Innovations, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ocugen Inc.
Tier 1ProductionApproval-Gated PipelineRule
Cabaletta Bio Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zhejiang Zhenyuan Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
Jilin Jian Yisheng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlowRule
CapsoVision, Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Companies that share active interpretations — structural patterns currently present in both stocks.
Jinlihua Electric Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Fs Development Investment Co., Ltd.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Shift4 Payments Inc.
1 interpretationUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated